Welcome to our dedicated page for ACII.U news (Ticker: ACII.U), a resource for investors and traders seeking the latest updates and insights on ACII.U stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect ACII.U's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of ACII.U's position in the market.
Atlas Crest Investment Corp. II (NYSE: ACII.U) has priced its initial public offering (IPO) of 30,000,000 units at $10.00 each, set to begin trading on February 4, 2021. Each unit includes one share of Class A common stock and a quarter warrant for purchasing additional shares at $11.50. The offering closes on February 8, 2021, pending customary conditions. Cantor Fitzgerald acts as the sole book-running manager and has a 45-day option for an additional 4,500,000 units for over-allotments. The registration statement was effective as of February 3, 2021.
